Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen‐specific immunotherapy
- 22 June 1995
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 64 (3) , 216-221
- https://doi.org/10.1002/ijc.2910640313
Abstract
Some human tumors express known antigens that can be utilized as targets for specific immunotherapy. An absolute requirement for the efficacy of this therapeutic strategy is an adequate expression of the candidate antigen by all cells of the primary and metastatic tumor. To examine the presence and distribution of tumor‐associated antigens in metastatic breast cancer, we used PCR analysis and ethidium bromide staining to test the expression of genes of the MAGE family in 28 primary tumors and related metastatic samples. Overall, samples obtained from 7 of 28 patients revealed positive. However, 2 of 3 primary tumors positive for MAGE‐1 and/or MAGE‐3 had corresponding negative metastatic lesions. On the contrary, 4 of the 25 MAGE‐negative primary tumors gave rise to positive metastatic nodes. Our results confirm in vivo, at the molecular level, the tumor‐antigen heterogeneity previously observed at the cellular level by in vitro analysis. Our data strongly suggest that, at least in patients with breast cancer, multiple different antigens would be required to optimize the recognition of neoplastic cells in immunotherapeutic protocols using MAGE products as target antigens.Keywords
This publication has 17 references indexed in Scilit:
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601European Journal of Immunology, 1994
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.The Journal of Experimental Medicine, 1994
- A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.The Journal of Experimental Medicine, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- An explanation of the variable clinical response to interleukin 2 and LAK cellsImmunology Today, 1990
- Production of stable cytolytic T‐cell clones directed against autologous human melanomaInternational Journal of Cancer, 1987
- Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones.The Journal of Experimental Medicine, 1986
- Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.The Journal of Experimental Medicine, 1983